Back
Arbutus Biopharma Corp. Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
36
ABUS
Arbutus Biopharma Corp.
Last Price:
$4.13
Seasonality Move:
0.11%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.
Arbutus Biopharma Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.13 | Buy |
| 20-day SMA: | 4.48 | Sell |
| 50-day SMA: | 4.49 | Sell |
| 200-day SMA: | 3.91 | Buy |
| 8-day EMA: | 4.2 | Sell |
| 20-day EMA: | 4.37 | Sell |
| 50-day EMA: | 4.45 | Sell |
| 200-day EMA: | 4.08 | Buy |
Arbutus Biopharma Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 40.37 | Sell |
| Chaikin Money Flow: | -161776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.24 - 4.82) | Sell |
| Bollinger Bands (100): | (4.27 - 4.69) | Sell |
Arbutus Biopharma Corp. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arbutus Biopharma Corp. Stock
Is Arbutus Biopharma Corp. Stock a Buy?
-
Arbutus Biopharma Corp. share price is 4.14 while ABUS 8-day simple moving average is 4.13, which is a Buy signal.
-
The stock price of ABUS is 4.14 while Arbutus Biopharma Corp. 20-day SMA is 4.48, which makes it a Sell.
-
Arbutus Biopharma Corp. 50-day simple moving average is 4.49 while ABUS share price is 4.14, making it a Sell technically.
-
ABUS stock price is 4.14 and Arbutus Biopharma Corp. 200-day simple moving average is 3.91, creating a Buy signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
36
Arbutus Biopharma Corp. (ABUS)
is a Sell
Is Arbutus Biopharma Corp. a Buy or a Sell?
-
Arbutus Biopharma Corp. stock is rated a SellThe current Arbutus Biopharma Corp. [ABUS] share price is $4.14. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Corp. Stock Info
Market Cap:
790.5M
Price in USD:
4.14
Share Volume:
1.2M
Arbutus Biopharma Corp. 52-Week Range
52-Week High:
5.10
52-Week Low:
2.71
Sell
36
Arbutus Biopharma Corp. (ABUS)
is a Sell
Arbutus Biopharma Corp. Share Price Forecast
-
What is the Arbutus Biopharma Corp. stock price today?The Arbutus Biopharma Corp. stock price is 4.14 USD today.
-
Will ABUS stock go up or go down?Arbutus Biopharma Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is Arbutus Biopharma Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma Corp. is overvalued.
Is Arbutus Biopharma Corp. Stock a Buy?
-
Arbutus Biopharma Corp. share price is 4.14 while ABUS 8-day exponential moving average is 4.20, which is a Sell signal.
-
The stock price of ABUS is 4.14 while Arbutus Biopharma Corp. 20-day EMA is 4.37, which makes it a Sell.
-
Arbutus Biopharma Corp. 50-day exponential moving average is 4.45 while ABUS share price is 4.14, making it a Sell technically.
-
ABUS stock price is 4.14 and Arbutus Biopharma Corp. 200-day simple moving average is 4.08, creating a Buy signal.
Fundamental Analysis of Arbutus Biopharma Corp.
Is Arbutus Biopharma Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Arbutus Biopharma Corp.
Should I short Arbutus Biopharma Corp. stock?
-
ABUS Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Arbutus Biopharma Corp. is a Sell
-
Arbutus Biopharma Corp. Relative Strength Index (RSI) is 40.37, which suggest Arbutus Biopharma Corp. is oversold
-
The Bollinger Bands (25) for Arbutus Biopharma Corp. is (4.24 - 4.82), which suggest Arbutus Biopharma Corp. is a Sell
-
The Bollinger Bands (100) for Arbutus Biopharma Corp. is (4.27 - 4.69), which suggest Arbutus Biopharma Corp. is a Sell
* Arbutus Biopharma Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.